Over recent months One Nucleus has consulted widely on the why, what, and who aspects of choosing the right events to attend to balance cost, approaches, and expectations to meet the business needs most cost-effectively.
by Tony Jones, CEO, One Nucleus
In this article:
An exciting opportunity has arisen for a Project Coordinator to join Quadram Institute Bioscience (QIB)on a part-time basis (0.8 FTE, by negotiation) basis, providing coordination support to the Food Safety Research Network (FSRN) and, depending on the hours agreed, the AMR in Agrifood Systems Transdisciplinary Network (AMAST).
*Guest Article by Laura Murray, Head of Business Development, Cellular and Molecular Therapies, NHS Blood and Transplant (NHSBT). If you would like to submit an article or blog post please email [email protected].
As a Director, BioPharma R&D Strategy Analystyou will be responsible for connecting R&D strategy with commercial forecasting to improve the quality and impact of cross-functional decision-making.
Working across R&D and Commercial in a multidisciplinary team environment, the Director will lead the development oflong-term therapy area projections and strategic analyses that identify areas of high unmet need and inform portfolio prioritization.
Harness Therapeutics is seeking a Research Project Manager to drive the planning, coordination, and execution of our research programs at the Babraham Research Campus in Cambridge, one of the UK’s leading biotech hubs. The role presents an excellent opportunity for a talented and dynamic individual to advance their career and join an evolving biotech that is focused on the development of RNA-targeted therapeutics in neurodegenerative disease.
Celebrating the Canada-UK Biomanufacturing Partnership and a delegation of Canadian life sciences companies visiting London, the event will bring together leaders from industry, investment and innovation for a panel discussion exploring what influences where high-growth life sciences companies choose to scale.
The conversation will cover key considerations including access to capital, talent, infrastructure and markets, as well as the opportunities for collaboration between the Canadian and UK life sciences ecosystems.
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
Join us at our annual Life Sciences Conference, “Rewiring the legal protection of drug discovery: AI, data and innovation”, where our life sciences sector team, alongside industry experts, will explore how artificial intelligence is reshaping the discovery and development of new medicines.
Join the Eastern England Secure Data Environment (SDE) and Health Innovation East Midlands for the launch of a new webinar series demonstrating how the Eastern England SDE can support research and innovation by providing secure access to de-identified NHS patient data for analysis.